Aligos Therapeutics Inc (ALGS): Insights At A Glance
The Vanguard Group, Inc. has recently announced that it has increased stake in Aligos Therapeutics Inc (NASDAQ:ALGS) by 2.29%. After grabbing 1.01 million shares, the institutional investor is now in possession of 22600.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 2.50% having worth around $0.61 million. Moreover, […]
